Cibc World Market Inc. Sells 3,916 Shares of Teladoc Health, Inc. (NYSE:TDOC)

Cibc World Market Inc. decreased its holdings in shares of Teladoc Health, Inc. (NYSE:TDOCGet Rating) by 11.6% during the second quarter, HoldingsChannel reports. The institutional investor owned 29,958 shares of the health services provider’s stock after selling 3,916 shares during the period. Cibc World Market Inc.’s holdings in Teladoc Health were worth $995,000 at the end of the most recent quarter.

A number of other hedge funds have also recently modified their holdings of TDOC. Daiwa Securities Group Inc. grew its stake in shares of Teladoc Health by 35.2% during the first quarter. Daiwa Securities Group Inc. now owns 9,985 shares of the health services provider’s stock valued at $720,000 after buying an additional 2,600 shares during the last quarter. National Asset Management Inc. grew its stake in Teladoc Health by 27.3% in the first quarter. National Asset Management Inc. now owns 8,612 shares of the health services provider’s stock worth $622,000 after purchasing an additional 1,848 shares in the last quarter. GoalVest Advisory LLC bought a new position in Teladoc Health in the first quarter worth approximately $31,000. FDx Advisors Inc. grew its stake in Teladoc Health by 47.6% in the first quarter. FDx Advisors Inc. now owns 11,837 shares of the health services provider’s stock worth $854,000 after purchasing an additional 3,816 shares in the last quarter. Finally, State of New Jersey Common Pension Fund D grew its stake in Teladoc Health by 3.3% in the first quarter. State of New Jersey Common Pension Fund D now owns 85,661 shares of the health services provider’s stock worth $6,179,000 after purchasing an additional 2,771 shares in the last quarter. Institutional investors own 92.46% of the company’s stock.

Insider Buying and Selling at Teladoc Health

In other Teladoc Health news, SVP Daniel Trencher sold 1,000 shares of Teladoc Health stock in a transaction dated Monday, September 19th. The stock was sold at an average price of $30.18, for a total transaction of $30,180.00. Following the completion of the transaction, the senior vice president now owns 25,408 shares in the company, valued at approximately $766,813.44. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In other Teladoc Health news, insider Arnnon Geshuri sold 4,098 shares of Teladoc Health stock in a transaction dated Friday, August 26th. The stock was sold at an average price of $34.27, for a total transaction of $140,438.46. Following the completion of the transaction, the insider now owns 76,182 shares in the company, valued at approximately $2,610,757.14. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Daniel Trencher sold 1,000 shares of the firm’s stock in a transaction dated Monday, September 19th. The shares were sold at an average price of $30.18, for a total value of $30,180.00. Following the sale, the senior vice president now owns 25,408 shares in the company, valued at $766,813.44. The disclosure for this sale can be found here. In the last quarter, insiders sold 6,845 shares of company stock worth $216,314. Insiders own 1.55% of the company’s stock.

Teladoc Health Stock Performance

Shares of TDOC stock opened at $28.79 on Monday. The company has a debt-to-equity ratio of 0.25, a quick ratio of 2.99 and a current ratio of 3.13. The business has a fifty day moving average of $27.82 and a 200 day moving average of $32.49. Teladoc Health, Inc. has a 1 year low of $23.08 and a 1 year high of $125.25.

Teladoc Health (NYSE:TDOCGet Rating) last issued its earnings results on Wednesday, October 26th. The health services provider reported ($0.45) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.59) by $0.14. The company had revenue of $611.40 million during the quarter, compared to analyst estimates of $609.45 million. Teladoc Health had a negative return on equity of 2.47% and a negative net margin of 424.40%. Equities research analysts anticipate that Teladoc Health, Inc. will post -1.4 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several research analysts recently issued reports on the company. Cowen dropped their price objective on Teladoc Health to $30.00 in a research note on Thursday, October 27th. Deutsche Bank Aktiengesellschaft dropped their price objective on Teladoc Health from $34.00 to $31.00 and set a “hold” rating on the stock in a research note on Tuesday, September 27th. StockNews.com started coverage on Teladoc Health in a research note on Wednesday, October 12th. They issued a “sell” rating on the stock. Cowen cut Teladoc Health from an “outperform” rating to a “market perform” rating and dropped their target price for the company from $58.00 to $34.00 in a research report on Tuesday, August 2nd. Finally, Credit Suisse Group dropped their target price on Teladoc Health from $35.00 to $30.00 and set a “neutral” rating on the stock in a research report on Monday, October 31st. One analyst has rated the stock with a sell rating, twenty-three have issued a hold rating and five have assigned a buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Hold” and an average target price of $52.17.

Teladoc Health Profile

(Get Rating)

Teladoc Health, Inc engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. Its portfolio of services and solutions covers medical subspecialties from non-urgent, episodic needs like flu and upper respiratory infections, to chronic, complicated medical conditions like cancer and congestive heart failure.

Recommended Stories

Want to see what other hedge funds are holding TDOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teladoc Health, Inc. (NYSE:TDOCGet Rating).

Institutional Ownership by Quarter for Teladoc Health (NYSE:TDOC)

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.